Changes to the website
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4796

Next 25
Website Changes
04/20/2019 Cancer and the dopamine D2 receptor: a pharmacological perspective.
04/18/2019 Liquid Biopsy for Detection of Histone H3 Mutations in Pediatric Diffuse Midline Gliomas
04/15/2019 Successful treatment of brain radiation necrosis resulting from triple-negative breast cancer with Endostar and short-term hyperbaric oxygen therapy: a case report
04/15/2019 Use of metformin and outcome of patients with newly diagnosed glioblastoma - pooled analysis.
04/11/2019 `I Love What I Do` - Internationally Renowned Brain Surgeon Dr. Linda Liau
04/09/2019 Case Report in the Journal of Neurosurgery Highlights Potential of ONC201 in H3 K27M-mutant DIPG
04/09/2019 Optune Open Houses
04/09/2019 National Walk To End Brain Tumors
04/03/2019 Phase 2 study of Val-083 with radiation therapy for newly diagnosed
04/03/2019 New Glioblastoma Vaccine Shows Promising Results in Phase 1b Clinical Trial
04/03/2019 High frequency of H3K27M immunopositivity in adult thalamic glioblastoma.
03/31/2019 New glioblastoma vaccine shows promising results in phase Ib clinical trial
03/31/2019 Could £400-per-year drug cocktail be the key to beating one of the most-deadly cancers?
03/28/2019 New Strategies Take On the Worst Cancer—Glioblastoma
03/20/2019 Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma.
03/15/2019 First-Of-Its-Kind Treatment Beats Back Notorious Brain Tumor
03/14/2019 Optune Open Houses
03/13/2019 Newly Diagnosed Glioblastoma: A Review on Clinical Management
03/12/2019 Northwell neurosurgeons remove “glowing” brain tumor using breakthrough technology in Long Island first
03/12/2019 xCures to Implement an Intermediate Size Expanded Access Protocol for ONC201 in H3 K27M-mutant Gliomas
03/12/2019 A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma
03/10/2019 Triple-drug Therapy With Bevacizumab, Irinotecan, and Temozolomide Plus Tumor Treating Fields for Recurrent Glioblastoma: A Retrospective Study.
03/09/2019 Update on Medicare CAC meeting
03/09/2019 National Walk To End Brain Tumors
03/09/2019 Optune Open House



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740